Interleukin 6 but not interleukin 10 is associated with restenosis after coronary stenting

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 193-194

  Ezhov, Marat V ^a   Sumarokov, Alexander B ^a   Raimbekova, Indira R ^a   Masenko, Valery P ^a   Naumov, Vladimir G ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESTENOSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0038645105     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00130-8     Document Type: Letter

References (5)

1. Morice M.-C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New Engl. J. Med. 346:2002;1773-1780.
2. Marx S.O., Marks A.R. The development of rapamycin and its application to stent restenosis. Circulation. 104:2001;852-855.
3. Smith D.A., Irving S.D., Sheldon J., Cole D., Kaski J.C. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 104:2001;746-749.
4. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N., Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 159:2001;137-144.
5. Hojo Y., Ikeda U., Katsuki T., et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart. 84:2000;83-87.